Company / Operating Income
Evolent Health, Inc. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$410.1M
FY2025
5-year range
-$410.1M / $3.6M
FY2021-FY2025
Trend
-913.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income changed -913% YoY in FY2025, a notable deviation from the 9-year average annual change of -352%.
Based on SEC 10-K filings.
-$410M in FY2025.
Declined from -$71M to -$410M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income decreased 913.1% year-over-year.
- Peak operating income was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$410.1M | -913.1% |
| FY2024 | -$40.5M | +43.1% |
| FY2023 | -$71.2M | -2055.3% |
| FY2022 | $3.6M | +108.6% |
| FY2021 | -$42.4M | +83.9% |
| FY2020 | -$262.8M | +14.9% |
| FY2019 | -$308.9M | -550.6% |
| FY2018 | -$47.5M | +34.8% |
| FY2017 | -$72.8M | +69.3% |
| FY2016 | -$237.4M | -452.5% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026